MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$74,274K
Net Income
-$17,582K
Net Profit Margin
-23.67%
EPS
-$0.21
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Product revenue, net
74,274
58,301
57,584
49,504
Cost of revenue
15,096
11,996
7,647
6,190
Gross profit
59,178
46,305
49,937
43,314
Research and development
7,813
7,771
7,493
7,027
Selling, general and administrative
55,330
54,011
48,372
51,558
Total operating expenses
63,143
61,782
55,865
58,585
Loss from operations
-3,965
-15,477
-5,928
-15,271
Interest income
1,510
1,736
1,204
1,413
Interest expense
15,103
15,797
16,418
16,108
Other expense, net
-24
-831
-6
-7
Total other expense
-13,617
-14,892
-15,220
-14,702
Net loss and comprehensive loss
-17,582
-30,369
-21,148
-29,973
Basic EPS
-0.21
-0.37
-0.286
-0.41
Diluted EPS
-0.21
-0.37
-0.286
-0.41
Basic Average Shares
83,747,104
82,050,618
73,843,007
73,396,435
Diluted Average Shares
83,747,104
82,050,618
73,843,007
73,396,435
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss and
comprehensive loss
-$17,582K
(76.81%↑ Y/Y)
Product revenue, net
$74,274K
(88.02%↑ Y/Y)
Total other expense
-$13,617K
(14.28%↑ Y/Y)
Loss from operations
-$3,965K
(93.38%↑ Y/Y)
Interest income
$1,510K
(-15.50%↓ Y/Y)
Gross profit
$59,178K
(71.70%↑ Y/Y)
Cost of revenue
$15,096K
(199.64%↑ Y/Y)
Interest expense
$15,103K
(-13.79%↓ Y/Y)
Total operating
expenses
$63,143K
(-33.10%↓ Y/Y)
Other expense, net
-$24K
(84.52%↑ Y/Y)
Selling, general and
administrative
$55,330K
(-35.14%↓ Y/Y)
Research and development
$7,813K
(-13.92%↓ Y/Y)
Buy us a coffee
Phathom Pharmaceuticals, Inc. (PHAT)
Phathom Pharmaceuticals, Inc. (PHAT)